In this regard, adipokines, i.e., PEDF and chemerin, may provide a metabolic link between obesity and RA or other autoimmune diseases, and as such they could be possible biomarkers of the effect of weight loss and of the decreased fat tissue in chronic inflammatory diseases. The gene discussed is SERPINF1; the disease is obesity disorder.